« go back

New funding for vaccines for global epidemics

The Department of Health is to invest up to £25 million in projects to develop new vaccines against infectious diseases. This competition will support projects seeking to develop candidate vaccines and vaccine platform technologies at the preclinical stage. The aim is to enable an effective and rapid response during future outbreaks of disease. 


Competition scope

This competition aims to support the preclinical development of candidate vaccines against 12 diseases. The UK Vaccine Network has identified these diseases as a priority as they have the potential to cause epidemics in low and middle-income countries.

  • chikungunya
  • Crimean-Congo haemorrhagic fever
  • ebola
  • hantavirus
  • lassa
  • marburg
  • Middle-East respiratory syndrome
  • nipah
  • plague
  • Q fever
  • Rift Valley fever
  • zika


About the competition

The competition has two stages:

  • Stage 1: exploring the scientific, technical and commercial feasibility of candidate vaccines and vaccine technologies. They expect projects to last for up to 12 months
  • Stage 2: carrying out late stage preclinical and early clinical work, based on the results of Stage 1. They expect projects to last for up to 24 months

This is a Small Business Research Initiative (SBRI) competition run in partnership with the Department of Health and the Medical Research Council. It is open to organisations of all sizes. Academic, industry and government bodies may all apply for funding.


Key dates

Registration deadline: 12 noon on 21 December 2016

Application deadline: 12 noon on 4 January 2017


Further information

Find out more at

No comments yet. Be the first.


Subscribe to our updates

Subscribe to our newsletters
Follow us on twitter

Join us on LinkedIn

Keep up to date with the latest agri-food and biosciences news, events, funding opportunities and more.

Got a Question?


Email us Email Us
Contact a member of our team